Skip to main content
https://pbs.twimg.com/media/D9AJkxLVUAAGqNC.jpg
Baracitinib affects JAK2 more than Tofacitinib. Difference can be seen with lower Hb & higher platelets #EULAR2019 https://t.co/BfzuyZI8f9
Dr Irwin Lim
Jun-14-2019
×